“This is a game changer for companies looking for a Chair or NED. A powerful FREE tool.”

Anthony Chadwick CEO Alpha Vet International

Register to post jobs to our network FREE

You're all set

You’re about to join an exclusive membership club of highly skilled and aspiring Non-Exec’s. No up-sells, no gimmicks, just the expert tools to develop your portfolio career.

Only £149
LIMITED TIME OFFER!

Join Now

Send message to The VirtualNonExec Team

Send message to Maddy

Maddy Kennedy

Leicestershire

Learn more about Maddy Contact Maddy

Maddy Kennedy

Leicestershire

Learn more about Maddy Contact Maddy

About Maddy

An experienced NED and CFO in both public and private companies, largely in life science and technology sectors, particularly in entrepreneurial businesses undertaking strategic review, M&A, an IPO or a funding round.
Current roles:
NED at Nuformix plc - drug repurposing company
CFO of Arquer Diagnostics - oncology diagnostics
Previous roles
Interim CFO roles include MyHealthChecked, Ieso Digital Health and Psioxus Therapeutics, in all cases supporting the management team through their next stage of growth. Previously CFO for Lab21, through its restructure and refinancing and Finance Director at Alliance Pharma plc from start-up through to the IPO on AIM.
FCCA and with a Post Graduate Diploma (distinction) in Financial Strategy from Said Business School, Oxford.
Experienced Life Sciences / Biotech / Pharma NED


Maddy's Career History

Nuformix plc

Non-Executive Director

January 2020 - Ongoing

Pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. NED and chair of Audit committee, also member of Remuneration Committee

CFO4Growth

CEO

June 2010 - Ongoing

Lab21 Ltd

CFO

May 2007 - September 2010

Alliance Pharma plc

Finance Director

May 1999 - May 2007

Endorsements

Garrick Bruce

29/06/2020

Maddy is highly accomplished and skilled CFO and board advisor. The accomplishments speak for themselves and two that really stood out to me were, a successful raise of circa £2M during Covid19 and her restructure and refocus of Lab21 which then increased revenue by a multiplier of 4 and reduced all loss making activities. I highly recommend Maddy as a financially focused NED

Sectors

+ Digital Healthcare Pharmaceutical Technology